Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.060
-0.120 (-5.50%)
Mar 24, 2026, 3:56 PM EDT - Market open
Nkarta Market Cap
Nkarta has a market cap or net worth of $146.32 million as of March 24, 2026. Its market cap has increased by 12.69% in one year.
Market Cap
146.32M
Enterprise Value
-59.38M
1-Year Change
12.69%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $146.32M, a decrease of -90.01%. That is a compound annual growth rate of -33.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 154.84M | 17.84% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 163.07M |
| Korro Bio | 162.54M |
| Evaxion | 161.80M |
| Precision BioSciences | 161.22M |
| ProMIS Neurosciences | 159.36M |
| Humacyte | 159.24M |
| Sagimet Biosciences | 159.02M |
| Immunic | 152.64M |